C. Andrew Kistler, MD, PharmD

Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.

All articles by C. Andrew Kistler, MD, PharmD

Obesity Information Center

IBD and Obesity: Is There a Connection?

C. Andrew Kistler, MD, PharmD

October 13, 2021

One key factor that has developed increasing research interest is the role of a patient’s BMI, specifically those with obesity (BMI > 30 kg/m2), in the development of IBD.

Gastroenterology Information Center

IBD and Osteoporosis: Key Takeaways and New Data

C. Andrew Kistler, MD, PharmD

August 27, 2021

Reviewing a patient’s potential risk for osteoporosis should be a routine part of each visit for patients with IBD.

Gastroenterology Information Center, Infectious Diseases Information Center

COVID-19 and IBD: Impact of Disease State and Biologics

C. Andrew Kistler, MD, PharmD

June 9, 2021

In patients with IBD, management of immunosuppressive regimens, as well as safety and efficacy of vaccines, has raised many questions during the COVID-19 pandemic.